Uncategorized
Featured Stories
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
New Research Affirms Increase in Access, Equity of COVID-19 Vaccines Administered in Dialysis Centers
Results demonstrate the importance of vaccinating patients at trusted sites of care DENVER and WALTHAM, Mass., April 4, 2022 /PRNewswire/ — A federal partnership established to help increase…
-
DaVita Clinical Research Study Finds Efficacy of Common COVID-19 Vaccines at Parity for Kidney Patients
Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis…
-
DaVita Kidney Care Appoints New Chief Medical Officer of Home Modalities
DaVita Kidney Care today announced Dr. Mihran Naljayan as chief medical officer (CMO) of Home Modalities. Dr. Naljayan joined DaVita in 2016 and most recently served as vice president of clinical…
-
DaVita expands paid leave to support teammates choosing to be living organ donors
In honor of National Donor Day—and every living organ donor—DaVita announced it increased paid leave for organ donation to four consecutive weeks for benefits-eligible teammates (employees)…
-
DaVita Inc. 4th Quarter 2021 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2021. “COVID continues to evolve and have a direct impact on our world, especially on…